Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Surgicept is a waterless, alcohol-based topical antiseptic solution designed for use as a surgical hand scrub and healthcare personnel handwash. Developed by Healthpoint and later distributed by CareFusion, the formulation contains 70% ethyl alcohol as the primary active ingredient, supplemented by preservative levels of chlorhexidine gluconate (CHG) and benzalkonium chloride (BZK) in a synergistic combination with ethylhexylglycerin. It is intended to significantly reduce microorganisms on the hands and forearms prior to surgery or patient care, demonstrating rapid bactericidal activity with a 99.99% kill rate within 15 seconds in vitro. The product was originally invented by Dr. Shanta M. Modak at Columbia University Medical Center and meets FDA requirements for surgical hand scrubs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Surgicept.